David Malka
Inserm(FR)Université Paris-Saclay(FR)Institut Gustave Roussy(FR)Institute Mutualiste Montsouris(FR)Intergroupe Francophone de Cancérologie Thoracique(FR)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Pancreatic and Hepatic Oncology Research, Cholangiocarcinoma and Gallbladder Cancer Studies, Genetic factors in colorectal cancer, Hepatocellular Carcinoma Treatment and Prognosis
Most-Cited Works
- → FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer(2018)2,781 cited
- → Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up(2022)571 cited
- → Cutaneous side-effects of kinase inhibitors and blocking antibodies(2005)545 cited
- → Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study(2019)511 cited
- → Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE‐158 and KEYNOTE‐028 studies(2020)488 cited
- → Risk of pancreatic adenocarcinoma in chronic pancreatitis(2002)455 cited